Preoperative management of hypoplastic left heart syndrome

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 5, 2005, Pages 687-693

  Graham, Eric M ^a   Bradley, Scott M ^a   Atz, Andrew M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Congenital heart disease; Hypoplastic left heart syndrome; Prostaglandin; Single ventricle

Indexed keywords

ADRENALIN; CARBON DIOXIDE; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; ISOPRENALINE; METHYLPREDNISOLONE; MIDAZOLAM; MILRINONE; MORPHINE; NITRIC OXIDE; NITROGEN; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; PHENOXYBENZAMINE; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN E1; SILDENAFIL; VASOPRESSIN; VECURONIUM;

APNEA; BRADYCARDIA; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORTICOSTEROID THERAPY; DRUG COST; EXPERIENCE; FATALITY; FEVER; HEART HEMODYNAMICS; HEART OUTFLOW TRACT OBSTRUCTION; HEART OUTPUT; HEART RIGHT VENTRICLE; HEART SINGLE VENTRICLE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; HYPOTENSION; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG INJURY; LUNG VASCULAR RESISTANCE; MEDICAL LITERATURE; METHEMOGLOBINEMIA; NEUROMUSCULAR BLOCKING; NEWBORN; OXYGEN THERAPY; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PULMONARY HYPERTENSION; REVIEW; SEDATION; SURVIVAL RATE; SYSTEMIC CIRCULATION; THROMBOCYTE DYSFUNCTION; TISSUE OXYGENATION; VASCULAR PATENCY; VASODILATATION;

CARDIOVASCULAR AGENTS; DISEASE MANAGEMENT; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; PREOPERATIVE CARE;

EID: 19144362926     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.5.687     Document Type: Review

References (38)

1. FYLER DC: Report of the New England regional infant cardiac program. Pediatrics (1980) 65(Suppl.):377-461.
2. PERRY LW, NEILL CA, FERENCZ C et al.: Infants with congenital heart disease: the cases. In: Perspectives in pediatric cardiology: Epidemiology of congenital heart disease, the Baltimore-Washington infant study 1981-1989. Ferencz C, Rubin JD, Loffredo CA et al. (Eds), Futura Publishing Company, Inc., Mount Kisco. NY (1993):33-62.
3. NORWOOD WI, LANG P, HANSEN DD: Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N. Engl. J. Med. (1983) 308:23-26.
4. BRADLEY SM, SIMSIC JM, MCQUINN TC, HABIB DM, SHIRALI GS, ATZ AM: Hemodynamic status after the Norwood procedure: a comparison of right ventricle-to-pulmonary artery connection versus modified Blalock-Taussig shunt. Ann. Thorac. Surg. (2004) 78:933-941.
5. TWEDDELL JS, HOFFMAN GM, FEDDERLY RT et al.: Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann. Thorac. Surg. (1999) 67:161-168.
6. BARNEA O, AUSTIN EH, RICHMAN B, SANTAMORE WP: Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J. Am. Coll. Cardiol. (1994) 24:1376-1381.
7. BARNEA O, SANTAMORE WP, ROSSI A et al.: Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation (1998) 98:1407-1413.
8. MIGLIAVACCA F, PENNATI G, DUBINI G et al.: Modeling of the Norwood circulation: effects of shunt size, vascular resistances, and heart rate. Am. J. Physiol. Heart Circ. Physiol. (2001) 280:H2076-H2086.
9. TAEED R, SCHWARTZ SM, PEARL JM et al.: Unrecognized pulmonary venous desaturation early after Norwood palliation confounds Qp:Qs assessment and compromises oxygen delivery. Circulation (2001) 103:2699-2704.
10. HOFFMAN GM, GHANAYEM NS, KAMPINE JM et al.: Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome. Ann. Thorac. Surg. (2000) 70:1515-1521.
11. HOFFMAN GM: Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion. J. Thorac. Cardiovasc. Surg. (2004) 127:223-233.
12. NAGDYMAN N: Relation of cerebral tissue oxygenation index to central venous oxygen saturation in children. Intensive Care Med. (2004) 30:468-471.
13. 1 in infants with congenital heart disease. Am. Heart. J. (1981) 101:837-843.
14. BOUCEK RJ, CHRISANT MRK: Cardiac transplantation for hypoplastic left heart syndrome. Cardiol Young (2004) 14:83-87.
15. DAY RW, BARTON AP, PYSHER TJ: Pulmonary vascular resistance of children treated with nitrogen during early infancy. Ann. Thorac. Surg. (1998) 65:1400-1404.
16. SHIME N, HASHIMOTO S, HIRAMATSU N et al.: Hypoxic gas therapy using nitrogen in the preoperative management of neonates with hypoplastic left heart syndrome. Pediatr. Crit. Care Med. (2000) 1:38-41.
17. CHANG AC, ZUCKER HA, HICKEY PR et al.: Pulmonary vascular resistance in infants after cardiac surgery: role of carbon dioxide and hydrogen ion. Crit. Care Med. (1995) 23:568-575.
18. JOBES DR, NICOLSON SC, STEVEN JM et al.: Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome. Ann. Thorac. Surg. (1992) 54:150-151.
19. RIORDAN CJ, RANDSBAEK F, STOREY JH, MONTGOMERY WD, SANTAMORE WP, AUSTIN EH: Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart. J. Thorac. Cardiovasc. Surg. (1996) 112:644-654.
20. BRADLEY SM, SIMSIC JM, ATZ AM: Hemodynamic effects of inspired carbon dioxide after the Norwood procedure. Ann. Thorac. Surg. (2001) 72:2088-2094.
21. TABBUTT S, RAMAMOORTHY C, MONTENEGRO LM et al.: Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circulation (2001) 104(Suppl. I):I-159-I-164.
22. ATZ AM, FEINSTEIN JA, JONAS RA, PERRY SB, WESSEL DL: Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am. J. Cardiol (1999) 83:1224-1228.
23. ROBERTS JD JR, LANG E BIGATELLO LM, VLAHAKES GJ, ZAPOL WM: Inhaled nitric oxide in congenital heart disease. Circulation (1993) 87:447-453.
24. CELERMAJER DS, CULLEN S, DEANFIELD JE: Impairment of endothelium-dependent pulmonary artery relaxadon in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation (1993) 87:440-446.
25. SCHEURER MA, BANDISODE V, ATZ AM: Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory with nasal cannula nitiric oxide. Circulation (2003) 108(Suppl.):IV-496.
26. ATZ AM, ADATIA L, WESSEL DL: Rebound pulmonary hypertension after inhalation of nitric oxide. Ann. Thorac. Surg. (1996) 62:1759-1764.
27. ATZ AM, WESSEL DL: Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology (1999) 91:307-310.
28. BRADLEY SM, ATZ AM, SIMSIC JM: Redefining the impact of oxygen and hyperventilation after the Norwood procedure. J. Thorac. Cardiovasc. Surg. (2004) 127:473-480.
29. WAN S, LECLERC JL, VINCENT JL: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest (1997) 112:676-692.
30. EDMUNDS LH Jr: Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg. (1998) 66:S12-S16.
31. JANSEN NJ, VAN OEVEREN W, VAN VLIET M et al.: The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. (1991) 5:211-217.
32. KAWAMURA T, INADA K, NARA N et al.: Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit. Care Med. (1999) 27:545-548.
33. BRONICKI RA, BACKER CL, BADEN HP et al.: Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann. Thorac. Surg. (2000) 69:1490-1495.
34. CHECCHIA PA, BACKER CL, BRONICKI RA et al.: Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit. Care Med. (2003) 31:1742-1745.
35. LODGE AJ, CHAI PJ, DAGGETT CW et al.: Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonaral piglets: Timing of dose is important. J. Thorac. Cardiovasc. Surg. (1999) 117:515-522.
36. DUFFY JY, NELSON DP, SCHWARTZ SM et al.: Glucocorticoids reduce cardiac dysfunction after cardioputmonary bypass and circulatory arrest in neonatal piglets. Pediatr. Crit. Care Med. (2004) 5:28-34.
37. ADATIA I, ATZ AM, JONAS RA, WESSEL DL: Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J. Thorac. Cardiovasc. Surg. (1996) 112:1403-1405.
38. MCELHINNEY DB, HEDRICK HL, BUSH DM et al.: Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics (2000) 106:1080-1087.